These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2957965)

  • 1. Plasmin induces acantholysis in skin organ cultures.
    Hunziker T; Vassalli JD
    Arch Dermatol Res; 1987; 279(5):341-6. PubMed ID: 2957965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organ culture model for the study of pemphigus acantholysis.
    Michel B; Ko CS
    Br J Dermatol; 1977 Mar; 96(3):295-302. PubMed ID: 322692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Naito K
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1231-8. PubMed ID: 2965270
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.
    Schiltz JR; Michel B
    J Invest Dermatol; 1976 Aug; 67(2):254-60. PubMed ID: 950490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis.
    Morioka S; Naito K; Ogawa H
    J Invest Dermatol; 1981 May; 76(5):337-41. PubMed ID: 7014725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis.
    Xue W; Hashimoto K; Toi Y
    J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z; Liu R; Ye Q
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus acantholysis in tissue culture: studies on photo-induction.
    Gschnait F; Pehamberger H; Holubar K
    Acta Derm Venereol; 1978; 58(3):237-9. PubMed ID: 78638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis.
    Naito K; Morioka S; Nakajima S; Ogawa H
    J Invest Dermatol; 1989 Jul; 93(1):173-7. PubMed ID: 2526184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody.
    Schiltz JR; Michel B; Papay R
    J Invest Dermatol; 1979 Dec; 73(6):575-81. PubMed ID: 512411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
    Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
    J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasminogen activator in pemphigus vulgaris.
    Wilkinson JE; Smith CA; Suter MM; Falchek W; Lewis RM
    Am J Pathol; 1989 Mar; 134(3):561-9. PubMed ID: 2466403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroid, retinoid, and protease inhibitors on the formation of acantholysis induced in organ culture of skins from patients with benign familial chronic pemphigus.
    Ikeda S; Ogawa H
    J Invest Dermatol; 1991 Oct; 97(4):644-8. PubMed ID: 1940435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW; Geoghegan WD; Jordon RE
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone inhibits pemphigus acantholysis in skin cultures.
    Swanson DL; Dahl MV
    J Invest Dermatol; 1983 Sep; 81(3):258-60. PubMed ID: 6886473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures.
    Hunziker T; Nydegger UE; Lerch PG; Vassalli JD
    Clin Exp Immunol; 1986 May; 64(2):442-9. PubMed ID: 3742881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.